Lv1
48 积分 2025-02-20 加入
Doxorubicin alone versus doxorubicin with trabectedin followed by trabectedin alone as first-line therapy for metastatic or unresectable leiomyosarcoma (LMS-04): a randomised, multicentre, open-label phase 3 trial
10天前
已完结
Doxorubicin–Trabectedin with Trabectedin Maintenance in Leiomyosarcoma
22天前
已完结
Data from Anlotinib plus TQB2450, a PD-L1 Antibody, in Patients with Advanced Alveolar Soft Part Sarcoma: A Single-Arm, Phase II Trial
22天前
已完结
Vimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
29天前
已完结
PARP Inhibition Induces Synthetic Lethality and Adaptive Immunity in LKB1-Mutant Lung Cancer
1个月前
已完结
16例儿童新型冠状病毒感染后合并不同类型脑病的MRI影像表现
1个月前
已采纳
bim技术在施工阶段成本控制应用研究
1个月前
已采纳
DNA甲基化与糖尿病肾病
1个月前
已采纳
皖公网安备34019202002308
